Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan H Shrimp

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Nature Communications|November 17, 2017
Assay interference and off-target liabilities of reported histone acetyltransferase inhibitorsJayme L Dahlin, Kathryn M Nelson, Jessica M Strasser, et al.
Biorxiv : the Preprint Server for Biology|February 16, 2022
A Suite of TMPRSS2 Assays for Screening Drug Repurposing Candidates as Potential Treatments of COVID-19Jonathan H Shrimp, John Janiszewski, Catherine Z Chen, et al.
ACS Infectious Diseases|June 1, 2022
Suite of TMPRSS2 Assays for Screening Drug Repurposing Candidates as Potential Treatments of COVID-19Jonathan H Shrimp, John Janiszewski, Catherine Z Chen, et al.
Frontiers in Pharmacology|October 31, 2025
Mass spectrometry-guided discovery of novel GCPII inhibitor scaffoldsRobyn Wiseman, Ajit G Thomas, John Janiszewski, et al.
Cell Chemical Biology|October 24, 2023
Methotrexate-based PROTACs as DHFR-specific chemical probesSandeep Rana, Patricia Dranchak, Jayme L Dahlin, et al.
Nature Chemical Biology|February 6, 2019
A chemoproteomic portrait of the oncometabolite fumarateRhushikesh A Kulkarni, Daniel W Bak, Darmood Wei, et al.
Cancer Discovery|August 21, 2021
PRC2 Inhibitors Overcome Glucocorticoid Resistance Driven by <i>NSD2</i> Mutation in Pediatric Acute Lymphoblastic LeukemiaJianping Li, Julia Hlavka-Zhang, Jonathan H Shrimp, et al.
Cell Chemical Biology|February 7, 2017
Discovering Targets of Non-enzymatic Acylation by Thioester Reactivity ProfilingRhushikesh A Kulkarni, Andrew J Worth, Thomas T Zengeya, et al.
Journal of Medicinal Chemistry|September 16, 2025
SAR Studies around the SULT1A1-Activated Alkylator YC-1 as Cytotoxic Agents against Biliary Tract Cancer CellsKe Kong, Wei Zhao, Jonathan H Shrimp, et al.
ACS Medicinal Chemistry Letters|June 18, 2021
Remodelin Is a Cryptic Assay Interference Chemotype That Does Not Inhibit NAT10-Dependent Cytidine AcetylationJonathan H Shrimp, Yihang Jing, Supuni Thalalla Gamage, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Nature Communications|November 17, 2017
Assay interference and off-target liabilities of reported histone acetyltransferase inhibitorsJayme L Dahlin, Kathryn M Nelson, Jessica M Strasser, et al.
Biorxiv : the Preprint Server for Biology|February 16, 2022
A Suite of TMPRSS2 Assays for Screening Drug Repurposing Candidates as Potential Treatments of COVID-19Jonathan H Shrimp, John Janiszewski, Catherine Z Chen, et al.
ACS Infectious Diseases|June 1, 2022
Suite of TMPRSS2 Assays for Screening Drug Repurposing Candidates as Potential Treatments of COVID-19Jonathan H Shrimp, John Janiszewski, Catherine Z Chen, et al.
Frontiers in Pharmacology|October 31, 2025
Mass spectrometry-guided discovery of novel GCPII inhibitor scaffoldsRobyn Wiseman, Ajit G Thomas, John Janiszewski, et al.
Cell Chemical Biology|October 24, 2023
Methotrexate-based PROTACs as DHFR-specific chemical probesSandeep Rana, Patricia Dranchak, Jayme L Dahlin, et al.
Nature Chemical Biology|February 6, 2019
A chemoproteomic portrait of the oncometabolite fumarateRhushikesh A Kulkarni, Daniel W Bak, Darmood Wei, et al.
Cancer Discovery|August 21, 2021
PRC2 Inhibitors Overcome Glucocorticoid Resistance Driven by <i>NSD2</i> Mutation in Pediatric Acute Lymphoblastic LeukemiaJianping Li, Julia Hlavka-Zhang, Jonathan H Shrimp, et al.
Cell Chemical Biology|February 7, 2017
Discovering Targets of Non-enzymatic Acylation by Thioester Reactivity ProfilingRhushikesh A Kulkarni, Andrew J Worth, Thomas T Zengeya, et al.
Journal of Medicinal Chemistry|September 16, 2025
SAR Studies around the SULT1A1-Activated Alkylator YC-1 as Cytotoxic Agents against Biliary Tract Cancer CellsKe Kong, Wei Zhao, Jonathan H Shrimp, et al.
ACS Medicinal Chemistry Letters|June 18, 2021
Remodelin Is a Cryptic Assay Interference Chemotype That Does Not Inhibit NAT10-Dependent Cytidine AcetylationJonathan H Shrimp, Yihang Jing, Supuni Thalalla Gamage, et al.
Pageof 4